Literature DB >> 34107350

Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.

Michael D E Sewell1, Lorena Jiménez-Sánchez2, Xueyi Shen3, Amelia J Edmondson-Stait2, Claire Green3, Mark J Adams4, Olivia M Rifai2, Andrew M McIntosh4, Donald M Lyall5, Heather C Whalley3, Stephen M Lawrie3.   

Abstract

Major depressive disorder (MDD), schizophrenia (SCZ), and bipolar disorder (BD) have both shared and discrete genetic risk factors, and are associated with peripheral abnormalities. The relationships between such genetic architectures and blood-based markers are, however, unclear. We investigated relationships between polygenic risk scores (PRS) for these disorders and peripheral markers in the UK Biobank cohort. We calculated polygenic risk scores for n = 367,329 (MDD PRS), n = 366,465 (SCZ PRS), and n = 366,383 (BD PRS) UK Biobank cohort subjects. We then examined associations between disorder PRS and 58 inflammatory/immune, hematological, bone, cardiovascular, hormone, liver, renal and diabetes-associated blood markers using two generalized linear regression models: 'minimally adjusted' controlling for variables such as age and sex, and 'fully adjusted' including additional lifestyle covariates: BMI, alcohol and smoking status, and medication intake. There were 38/58 MDD PRS, 32/58 SCZ PRS, and 20/58 BD PRS-blood marker associations detected for our minimally adjusted model. Of these, 13/38 (MDD PRS), 14/32 (SCZ PRS), and 10/20 (BD PRS) associations remained significant after controlling for lifestyle factors. Many were disorder-specific, with 8/13 unique MDD PRS associations identified. Several disorder-specific associations for MDD and SCZ were immune-related, with mostly positive and negative associations identified for MDD and SCZ PRS respectively. This study suggests that MDD, SCZ and BD have both shared and distinct peripheral markers associated with disorder-specific genetic risk. The results also implicate inflammatory dysfunction in MDD and SCZ, albeit with differences in patterns between the two conditions, and enrich our understanding of potential underlying pathophysiological mechanisms in major psychiatric disorders.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Blood markers; Major depressive disorder; Polygenic risk scores; Schizophrenia; UK Biobank

Mesh:

Year:  2021        PMID: 34107350     DOI: 10.1016/j.bbi.2021.06.002

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  2 in total

1.  The association between depression and bone metabolism: a US nationally representative cross-sectional study.

Authors:  Ming Ma; Xiaolong Liu; Gengxin Jia; Zhongcheng Liu; Kun Zhang; Liangzhi He; Bin Geng; Yayi Xia
Journal:  Arch Osteoporos       Date:  2022-08-13       Impact factor: 2.879

2.  Genetic variants associated with psychiatric disorders are enriched at epigenetically active sites in lymphoid cells.

Authors:  Mary-Ellen Lynall; Blagoje Soskic; James Hayhurst; Jeremy Schwartzentruber; Daniel F Levey; Gita A Pathak; Renato Polimanti; Joel Gelernter; Murray B Stein; Gosia Trynka; Menna R Clatworthy; Ed Bullmore
Journal:  Nat Commun       Date:  2022-10-15       Impact factor: 17.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.